BF Biosciences Limited (PSX:BFBIO)
Pakistan · Delayed Price · Currency is PKR 138.54
-1.64 (-1.17%)
At close: Mar 11, 2026
BF Biosciences Revenue
BF Biosciences had revenue of 2.67B PKR in the quarter ending December 31, 2025, with 101.03% growth. This brings the company's revenue in the last twelve months to 8.22B, up 81.98% year-over-year. In the fiscal year ending June 30, 2025, BF Biosciences had annual revenue of 5.84B with 59.55% growth.
Revenue (ttm)
8.22B
Revenue Growth
+81.98%
P/S Ratio
1.49
Revenue / Employee
15.37M
Employees
535
Market Cap
12.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.84B | 2.18B | 59.55% |
| Jun 30, 2024 | 3.66B | 1.85B | 102.19% |
| Jun 30, 2023 | 1.81B | 288.82M | 18.99% |
| Jun 30, 2022 | 1.52B | -234.10M | -13.34% |
| Jun 30, 2021 | 1.75B | 1.13B | 179.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unity Foods | 73.26B |
| The Thal Industries Corporation | 42.27B |
| Century Paper & Board Mills | 37.14B |
| Ittehad Chemicals | 30.57B |
| Archroma Pakistan | 28.03B |
| Avanceon | 14.42B |
| Macter International | 11.58B |
| Siemens (Pakistan) Engineering | 9.15B |